About Sambi Sciences
Sambi Sciences is a Healthcare company based in Hyderabad (India) founded in 2019 by Venkat Sambi Reddy. Provider of drugs development and contract manufacturing services for peptides. It operates on a Biopharma Outsourcing model. The company has 1 employees. Its chief executive, as recorded, is Dirk Sartor. Its Indian entity Sambi Life Sciences Private Limited reported revenue of ₹94.8 Lakh. Sambi Sciences offers products and services including Sambi Sciences Platform. Its focus areas include Diversified, Companies, Biopharma Outsourcing and Small Molecules and Peptides.
Company details
Sambi Sciences operates with a Biopharma Outsourcing model, focusing on diversified, companies, biopharma outsourcing, and companies that offer research and manufacturing services to biopharma industry. Provider of drugs development and contract manufacturing services for peptides. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Hyderabad, India
- Employees 1
- Founders Venkat Sambi Reddy
- SectorsHealthcare
- Website sambisciences.com
- Legal Name Sambi Life Sciences Private Limited
- Date of Incorporation 19 Jan, 2021
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹94.8 Lakh
FY 2024 · +1009% YoY
- Net Loss-₹37,320
FY 2024 · 0% margin
- EBITDA₹29.9 Lakh
FY 2024 · 32% margin
- Employee Count1
Associated legal entities of Sambi Sciences
Sambi Sciences operates through Sambi Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sambi Life Sciences Private Limited CIN U24290TG2021PTC147862 | Active | 19 Jan 2021 | Hyderabad, Telangana | ₹0.9 Cr | 5 | View details |
Products & Services of Sambi Sciences
Sambi Sciences offers a comprehensive portfolio of products and services, including Sambi Sciences Platform.
Provider of drugs development and contract manufacturing services for peptides
Board of directors of Sambi Life Sciences Private Limited (Sambi Sciences)
Sambi Life Sciences Private Limited is the primary company behind Sambi Sciences. The board of Sambi Life Sciences Private Limited currently have 5 directors; the longest-serving is Madhavi Reddy Sambireddy, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhavi Reddy Sambireddy DIN 02584592 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Krishnareddy Sambireddy DIN 03210173 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Sandesh Reddy Korandla DIN 08424926 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Hanmanth Pradeep Reddy DIN 08424925 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
| Venkat Narsimhareddy Sambi DIN 01629711 | Director | 19 Jan 2021 | 5 yrs 9 mo | Sambi Life Sciences Private Limited |
People of Sambi Sciences
2 people are tracked at Sambi Sciences (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Venkat Sambi Reddy | Founder | Leadership |
Dirk Sartor | CEO | Leadership |
Complete people profiles for Sambi Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sambi Sciences
Figures of Sambi Life Sciences Private Limited, the primary company behind Sambi Sciences, for FY 2024. Revenue was ₹94.8 Lakh (+1009% year on year). Net loss was -₹37,320 (0% margin). EBITDA was ₹29.9 Lakh (32% margin).
- ₹94.8 LakhRevenue · FY 2024 · +1009% YoY
- -₹37,320Net loss · 0% margin
- ₹29.9 LakhEBITDA · 32% margin
- ₹61 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Sambi Life Sciences Private Limited are on its company page.
Detailed financial statements for Sambi Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Sambi Sciences (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sambi Sciences
Sambi Sciences was founded in 2019.
Sambi Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Dirk Sartor is the CEO of Sambi Sciences, as recorded in our data.
Sambi Sciences has 1 employees.
The primary company behind Sambi Sciences, Sambi Life Sciences Private Limited, reported revenue of ₹94.8 Lakh for FY 2024, up 1009% year on year.
Sambi Sciences operates with a Biopharma Outsourcing model, focusing on diversified, companies, biopharma outsourcing, and companies that offer research and manufacturing services to biopharma industry. Provider of drugs development and contract manufacturing services for peptides. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Sambi Sciences offers Sambi Sciences Platform.
Sambi Sciences operates through Sambi Life Sciences Private Limited.
The legal entities of Sambi Sciences currently have 5 directors, including Madhavi Reddy Sambireddy, Krishnareddy Sambireddy, Sandesh Reddy Korandla and others.